K

KPX Lifescience Co Ltd
KOSDAQ:114450

Watchlist Manager
KPX Lifescience Co Ltd
KOSDAQ:114450
Watchlist
Price: 3 120 KRW -1.11% Market Closed
Market Cap: 62.4B KRW

Gross Margin
KPX Lifescience Co Ltd

1.2%
Current
-1%
Average
44.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
1.2%
=
Gross Profit
329.8m
/
Revenue
27.8B

Gross Margin Across Competitors

No Stocks Found

KPX Lifescience Co Ltd
Glance View

KPX LIFESCIENCE Co., Ltd. engages in the production and sale of pharmaceutical and agricultural raw materials and intermediates. The company is headquartered in Yeosu, Jeollanam-Do and currently employs 61 full-time employees. The company went IPO on 2009-12-22. The Company’s products consist of AMZ and CCIM, which are used as crop protection materials; EDP-CL, which is a antibiotic used as ingredient of piperacillin; PM06, which is used for treatment of allergic diseases, and DSIC, which is used as pharmaceutical intermediate. The firm also provides antibiotics and others. The firm distributes its products within domestic market and to overseas markets, including Japan, the United States, Europe and others.

KPX Lifescience Co Ltd Intrinsic Value
HIDDEN
Show
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
1.2%
=
Gross Profit
329.8m
/
Revenue
27.8B
What is the Gross Margin of KPX Lifescience Co Ltd?

Based on KPX Lifescience Co Ltd's most recent financial statements, the company has Gross Margin of 1.2%.

Back to Top